| Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies XR Yang, J Chang-Claude, EL Goode, FJ Couch, H Nevanlinna, RL Milne, ... Journal of the National Cancer Institute 103 (3), 250-263, 2011 | 841 | 2011 |
| Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial H Bartelink, P Maingon, P Poortmans, C Weltens, A Fourquet, J Jager, ... The lancet oncology 16 (1), 47-56, 2015 | 684 | 2015 |
| ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer BV Offersen, LJ Boersma, C Kirkove, S Hol, MC Aznar, AB Sola, ... Radiotherapy and oncology 114 (1), 3-10, 2015 | 565 | 2015 |
| Interobserver variations in gross tumor volume delineation of brain tumors on computed tomography and impact of magnetic resonance imaging C Weltens, J Menten, M Feron, E Bellon, P Demaerel, F Maes, ... Radiotherapy and Oncology 60 (1), 49-59, 2001 | 254 | 2001 |
| Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy R Hermans, M Meijerink, W Van den Bogaert, A Rijnders, C Weltens, ... International Journal of Radiation Oncology* Biology* Physics 57 (5), 1351-1356, 2003 | 251 | 2003 |
| ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1 BV Offersen, LJ Boersma, C Kirkove, S Hol, MC Aznar, AB Sola, ... Radiotherapy and oncology 118 (1), 205-208, 2016 | 212 | 2016 |
| Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial PM Poortmans, C Weltens, C Fortpied, C Kirkove, ... The Lancet Oncology 21 (12), 1602-1610, 2020 | 189 | 2020 |
| Quality assessment of medical decision making in radiation oncology: variability in target volume delineation for brain tumours G Leunens, J Menten, C Weltens, J Verstraete, E Van der Schueren Radiotherapy and Oncology 29 (2), 169-175, 1993 | 179 | 1993 |
| Preservation of parotid function with uncomplicated conformal radiotherapy A Maes, C Weltens, P Flamen, P Lambin, R Bogaerts, X Liu, J Baetens, ... Radiotherapy and oncology 63 (2), 203-211, 2002 | 166 | 2002 |
| Effectiveness of discharge interventions from hospital to home on hospital readmissions: a systematic review A Braet, C Weltens, W Sermeus JBI Evidence Synthesis 14 (2), 106-173, 2016 | 165 | 2016 |
| Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients K Erven, R Jurcut, C Weltens, S Giusca, J Ector, H Wildiers, ... International Journal of Radiation Oncology* Biology* Physics 79 (5), 1444-1451, 2011 | 151 | 2011 |
| Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC boost vs no boost trial: a randomized clinical trial C Vrieling, E van Werkhoven, P Maingon, P Poortmans, C Weltens, ... JAMA oncology 3 (1), 42-48, 2017 | 150 | 2017 |
| Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging L Morales, S Pans, R Paridaens, R Westhovens, D Timmerman, ... Breast cancer research and treatment 104, 87-91, 2007 | 148 | 2007 |
| Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy K Erven, A Florian, P Slagmolen, C Sweldens, R Jurcut, H Wildiers, ... International Journal of Radiation Oncology* Biology* Physics 85 (5), 1172-1178, 2013 | 141 | 2013 |
| De Gustibus: time scale of loss and recovery of tastes caused by radiotherapy A Maes, I Huygh, C Weltens, G Vandevelde, P Delaere, G Evers, ... Radiotherapy and Oncology 63 (2), 195-201, 2002 | 132 | 2002 |
| Dose–response relationships within the parotid gland after radiotherapy for head and neck cancer B Bussels, A Maes, P Flamen, P Lambin, K Erven, R Hermans, S Nuyts, ... Radiotherapy and oncology 73 (3), 297-306, 2004 | 129 | 2004 |
| Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive B Van Calster, I Vanden Bempt, M Drijkoningen, N Pochet, J Cheng, ... Breast cancer research and treatment 113, 181-187, 2009 | 126 | 2009 |
| European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Whole-breast irradiation with or without a boost for patients treated … H Bartelink, P Maingon, P Poortmans, C Weltens, A Fourquet, J Jager, ... Lancet Oncol 16 (1), 47-56, 2015 | 122 | 2015 |
| Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma R Hermans, P Lambin, A Van der Goten, W Van den Bogaert, B Verbist, ... Radiotherapy and Oncology 53 (2), 105-111, 1999 | 111 | 1999 |
| Tumour bed boost radiotherapy for women after breast‐conserving surgery I Kindts, A Laenen, T Depuydt, C Weltens Cochrane Database of Systematic Reviews, 2017 | 100 | 2017 |
